Amgen (Nasdaq: AMGN) and Cytokinetics Incorporated (Nasdaq: CYTK) announced the first presentation of data from the ATOMIC-AHF (Acute Treatment with ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE